Inventor
CHARIFSON PAUL S
US52 patents
⚠️ This page may combine multiple inventors who share the name “CHARIFSON PAUL S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
42 patentsUS9925188B2Mar 27, 2018
DNA-PK inhibitors and uses thereof
VERTEX PHARMA24 citations98
US9376448B2Jun 28, 2016
DNA-PK inhibitors
VERTEX PHARMA46 citations98
US6531474B1Mar 11, 2003
Inhibitors of caspases
VERTEX PHARMA62 citations96
US8829007B2Sep 9, 2014
Inhibitors of influenza viruses replication
VERTEX PHARMA28 citations95
US9592232B2Mar 14, 2017
DNA-PK inhibitors
VERTEX PHARMA24 citations94
US9878993B2Jan 30, 2018
DNA-PK inhibitors for treatment of cancer
VERTEX PHARMA10 citations92
US9808459B2Nov 7, 2017
Inhibitors of influenza viruses replication
VERTEX PHARMA11 citations92
US9518056B2Dec 13, 2016
Inhibitors of influenza viruses replication
VERTEX PHARMA16 citations92
US9394302B2Jul 19, 2016
Inhibitors of influenza viruses replication
VERTEX PHARMA19 citations92
US9359380B2Jun 7, 2016
DNA-PK inhibitors
VERTEX PHARMA19 citations92
US9345708B2May 24, 2016
Inhibitors of influenza viruses replication
VERTEX PHARMA21 citations92
US9340557B2May 17, 2016
Substituted quinoxaline DNA-PK inhibitors
VERTEX PHARMA19 citations92
US9296701B2Mar 29, 2016
DNA-PK inhibitors
VERTEX PHARMA21 citations92
US9051319B2Jun 9, 2015
Inhibitors of influenza viruses replication
VERTEX PHARMA24 citations92
US7727992B2Jun 1, 2010
Gyrase inhibitors and uses thereof
VERTEX PHARMA23 citations92
US7582641B2Sep 1, 2009
Gyrase inhibitors and uses thereof
VERTEX PHARMA21 citations92
US7569591B2Aug 4, 2009
Gyrase inhibitors and uses thereof
VERTEX PHARMA27 citations92
USRE40245EApr 15, 2008
Gyrase inhibitors and uses thereof
VERTEX PHARMA36 citations92
US7495014B2Feb 24, 2009
Gyrase inhibitors and uses thereof
VERTEX PHARMA25 citations91
US10973830B2Apr 13, 2021
Substituted quinoxaline DNA-PK inhibitors
VERTEX PHARMA3 citations84
US10786512B2Sep 29, 2020
DNA-PK inhibitors
VERTEX PHARMA3 citations84
US10501439B2Dec 10, 2019
DNA-PK inhibitors
VERTEX PHARMA5 citations84
US10442791B2Oct 15, 2019
DNA-PK inhibitors
VERTEX PHARMA5 citations84
US10391095B2Aug 27, 2019
DNA-PK inhibitors
VERTEX PHARMA5 citations84
US10258627B2Apr 16, 2019
DNA-PK inhibitors
VERTEX PHARMA4 citations84
US10076521B2Sep 18, 2018
DNA-PK inhibitors
VERTEX PHARMA7 citations84
US10039762B2Aug 7, 2018
Inhibitors of influenza viruses replication
VERTEX PHARMA7 citations84
US9987284B2Jun 5, 2018
Substituted benzooxadiazole DNA-PK inhibitors
VERTEX PHARMA5 citations84
US9908878B2Mar 6, 2018
Inhibitors of influenza viruses replication
VERTEX PHARMA8 citations84
US8871774B2Oct 28, 2014
Inhibitors of influenza viruses replication
VERTEX PHARMA18 citations83
US7517987B2Apr 14, 2009
Caspase inhibitors and uses thereof
VERTEX PHARMA6 citations74
US7358273B2Apr 15, 2008
Inhibitors of caspases
VERTEX PHARMA5 citations74
US7906650B2Mar 15, 2011
Caspase inhibitors and uses thereof
VERTEX PHARMA1 citations63
US12251387B2Mar 18, 2025
Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors
VERTEX PHARMA0 citations62
US11813267B2Nov 14, 2023
DNA-PK inhibitors
VERTEX PHARMA0 citations62
US11021465B2Jun 1, 2021
DNA-PK inhibitors
VERTEX PHARMA0 citations62
US11008305B2May 18, 2021
DNA-PK inhibitors
VERTEX PHARMA0 citations62
US8969359B2Mar 3, 2015
Gyrase and topoisomerase IV inhibitors
VERTEX PHARMA3 citations60
US12005127B2Jun 11, 2024
DNA-PK inhibitors
VERTEX PHARMA0 citations52
US10874673B2Dec 29, 2020
Inhibitors of influenza viruses replication
VERTEX PHARMA0 citations52
US10875855B2Dec 29, 2020
Inhibitors of influenza viruses replication
VERTEX PHARMA0 citations52
US7863449B2Jan 4, 2011
Modulators of muscarinic receptors
VERTEX PHARMA0 citations40
GOLEC JULIAN M C
2 patentsSPERO TRINEM INC
2 patentsCHARIFSON PAUL S
1 patentLE TIRAN ARNAUD
1 patentWANNAMAKER MARION W
1 patentPRAXIS PREC MEDICINES INC
1 patentShowing the top 50 of 52 patents by PatentIndex Score.